Chengping Hu
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
Papers in
-
- Lung Cancer Treatments and Mutations 32
- Co-authors
- Yi‐Long Wu (17 shared papers)Shun Lü (16 shared papers)Caicun Zhou (8 shared papers)Jifeng Feng (10 shared papers)Mei Hou (8 shared papers)Dan Massey (5 shared papers)Jian Hua Shi (5 shared papers)Wěi Li (5 shared papers)
- Journals
- Annals of Oncology (9 papers)Journal of Clinical Oncology (8 papers)Journal of Thoracic Oncology (7 papers)PLoS ONE (5 papers)Sleep And Breathing (3 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Chengping Hu
192 papers receiving 5.9k citations
Chengping Hu's Hit Papers
Peers
Comparison fields: 5 of 130
- Pulmonary and Respiratory Medicine 2.6k
- Cancer Research 1.0k
- Oncology 1.8k
- Immunology 606
- Molecular Biology 1.8k
Countries citing papers authored by Chengping Hu
This map shows the geographic impact of Chengping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengping Hu more than expected).
Fields of papers citing papers by Chengping Hu
This network shows the impact of papers produced by Chengping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengping Hu. The network helps show where Chengping Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chengping Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 198 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial Hit paper breakdown → | 2014 | 1608 |
| 2 | 2019 | 267 | |
| 3 | 2016 | 214 | |
| 4 | 2017 | 146 | |
| 5 | 2017 | 136 | |
| 6 | 2018 | 132 | |
| 7 | 2013 | 113 | |
| 8 | 2020 | 109 | |
| 9 | Competing endogenous RNA in cancer: a new pattern of gene expression regulation. | 2015 | 100 |
| 10 | 2019 | 98 | |
| 11 | 2011 | 87 | |
| 12 | 2017 | 80 | |
| 13 | 2020 | 78 | |
| 14 | 2015 | 76 | |
| 15 | 2016 | 71 | |
| 16 | 2013 | 67 | |
| 17 | 2018 | 67 | |
| 18 | 2012 | 66 | |
| 19 | 2018 | 61 | |
| 20 | 2013 | 55 |
About Chengping Hu
Chengping Hu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Physiology and Cancer Research, having authored 198 papers that have together received 6.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Research Studies (15 papers), Asthma and respiratory diseases (15 papers), MicroRNA in disease regulation (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Colorectal Cancer Treatments and Studies (8 papers), Immune Response and Inflammation (7 papers) and Cancer-related molecular mechanisms research (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.6k citations), Cancer Research (1.0k citations), Oncology (1.8k citations), Immunology (606 citations) and Molecular Biology (1.8k citations). Chengping Hu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yi‐Long Wu, Shun Lü, Caicun Zhou, Jifeng Feng, Mei Hou, Dan Massey, Jian Hua Shi, Wěi Li, Sarayut Lucien Geater and Yunchao Huang. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Journal of Thoracic Oncology, PLoS ONE and Sleep And Breathing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.